Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1893641rdf:typepubmed:Citationlld:pubmed
pubmed-article:1893641lifeskim:mentionsumls-concept:C0022658lld:lifeskim
pubmed-article:1893641lifeskim:mentionsumls-concept:C0003015lld:lifeskim
pubmed-article:1893641pubmed:issue8 Suppl 4lld:pubmed
pubmed-article:1893641pubmed:dateCreated1991-10-24lld:pubmed
pubmed-article:1893641pubmed:abstractTextRecent experimental studies suggest that the resistance state of the preglomerular and postglomerular capillary arterioles may determine if a particular class of antihypertensive agents will protect the kidney from hemodynamically mediated glomerular injury. This review discusses (1) the effects of angiotensin II on the renal microcirculation, (2) the pathophysiology of essential hypertensive renal disease, (3) the renal pharmacology of angiotensin-converting enzyme (ACE) inhibitors, and (4) the hypothesis that renal protection is dependent on control of systemic and glomerular hypertension.lld:pubmed
pubmed-article:1893641pubmed:languageenglld:pubmed
pubmed-article:1893641pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1893641pubmed:citationSubsetIMlld:pubmed
pubmed-article:1893641pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1893641pubmed:statusMEDLINElld:pubmed
pubmed-article:1893641pubmed:monthAuglld:pubmed
pubmed-article:1893641pubmed:issn0160-9289lld:pubmed
pubmed-article:1893641pubmed:authorpubmed-author:BauerJ HJHlld:pubmed
pubmed-article:1893641pubmed:authorpubmed-author:ReamsG PGPlld:pubmed
pubmed-article:1893641pubmed:issnTypePrintlld:pubmed
pubmed-article:1893641pubmed:volume14lld:pubmed
pubmed-article:1893641pubmed:ownerNLMlld:pubmed
pubmed-article:1893641pubmed:authorsCompleteYlld:pubmed
pubmed-article:1893641pubmed:paginationIV38-43; discussion IV51-5lld:pubmed
pubmed-article:1893641pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:1893641pubmed:meshHeadingpubmed-meshheading:1893641-...lld:pubmed
pubmed-article:1893641pubmed:meshHeadingpubmed-meshheading:1893641-...lld:pubmed
pubmed-article:1893641pubmed:meshHeadingpubmed-meshheading:1893641-...lld:pubmed
pubmed-article:1893641pubmed:meshHeadingpubmed-meshheading:1893641-...lld:pubmed
pubmed-article:1893641pubmed:meshHeadingpubmed-meshheading:1893641-...lld:pubmed
pubmed-article:1893641pubmed:meshHeadingpubmed-meshheading:1893641-...lld:pubmed
pubmed-article:1893641pubmed:meshHeadingpubmed-meshheading:1893641-...lld:pubmed
pubmed-article:1893641pubmed:year1991lld:pubmed
pubmed-article:1893641pubmed:articleTitleACE inhibitors in renal disease.lld:pubmed
pubmed-article:1893641pubmed:affiliationDepartment of Medicine, University of Missouri, Columbia 65212.lld:pubmed
pubmed-article:1893641pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1893641pubmed:publicationTypeReviewlld:pubmed